MNKD - MannKind Corp Net earnings per share (EPS TTM)

Symbol and logo of brand MannKind Corp. (MNKD)

Steady demand for inhalation therapy and partnership royalties ensure a confident capital inflow for MannKind Corporation (MNKD). Local production in the US mitigates geopolitical risks, although the import of Asian components remains vulnerable. Efficient pharmaceutical logistics guarantee the integrity of medications during delivery. The change in per-unit profit over the last 12 months demonstrates current dynamics, where the current value is -0.24.

MNKD (MannKind Corporation) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/17/2026

MNKD (MannKind Corp.): analytical breakdowns and indicator data

Analysis of all company metrics:MNKD - MannKind Corp.
Mass-produced product of MannKind Corp

The resilience of MannKind Corporation (MNKD) is based on the patent protection of its technologies, despite a significant dependence on external distributors. Analyzing the company's EPS TTM dynamics on GURU.Markets, an investor can see the net profit allocated per share over a year, which allows for an assessment of the business's real yield after all expenses. This indicator serves as the basis for determining the asset's fair value amid capital volatility.

Direct competitors

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|ANIP - Earnings per share for the last twelve months|amphastar.com (AMPH) - Net earnings per share for the last 12 months|PCRX: Net earnings per share (EPS TTM)|SPRY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Theravance|Net earnings per one share for the last twelve months Aquestive Corp AQST|Net earnings per share (EPS TTM) SCPH|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP